Background-Pulmonary hypertension occurs in chronic hypoxic lung diseases, significantly worsening morbidity and mortality. The important role of altered bone morphogenetic protein (BMP) signaling in pulmonary hypertension was first suspected after the identification of heterozygous BMP receptor mutations as the underlying defect in the rare heritable form of pulmonary arterial hypertension. Subsequently, it was demonstrated that BMP signaling was also reduced in common forms of pulmonary hypertension, including hypoxic pulmonary hypertension; however, the mechanism of this reduction has not previously been elucidated. Methods and Results-Expression of 2 BMP antagonists, gremlin 1 and gremlin 2, was higher in the lung than in other organs, and gremlin 1 was further increased in the walls of small intrapulmonary vessels of mice during the development of hypoxic pulmonary hypertension. Hypoxia stimulated gremlin secretion from human pulmonary microvascular endothelial cells in vitro, which inhibited endothelial BMP signaling and BMP-stimulated endothelial repair. Haplodeficiency of gremlin 1 augmented BMP signaling in the hypoxic mouse lung and reduced pulmonary vascular resistance by attenuating vascular remodeling. Furthermore, gremlin was increased in the walls of small intrapulmonary vessels in idiopathic pulmonary arterial hypertension and the rare heritable form of pulmonary arterial hypertension in a distribution suggesting endothelial localization. Conclusions-These findings demonstrate a central role for increased gremlin in hypoxia-induced pulmonary vascular remodeling and the increased pulmonary vascular resistance in hypoxic pulmonary hypertension. High levels of basal gremlin expression in the lung may account for the unique vulnerability of the pulmonary circulation to heterozygous mutations of BMP type 2 receptor in pulmonary arterial hypertension. (Circulation. 2012;125:920-930.)
P ulmonary hypertension is a disease of the pulmonary circulation characterized by a sustained increase in pulmonary arterial pressure caused by an abnormally elevated pulmonary vascular resistance. 1 The development of increased vascular resistance and hypertension in hypoxia is a response unique to the pulmonary circulation; in all other organs, hypoxia causes a reduction in resistance. 2 Chronic hypoxic lung diseases are commonly complicated by pulmonary hypertension, leading to right heart failure and significantly increasing morbidity and mortality. 3 Other forms of pulmonary hypertension include those caused by right-to-left cardiac shunt, connective tissue diseases, and idiopathic pulmonary arterial hypertension (IPAH), all of which are associated with a poor prognosis. 4
Clinical Perspective on p 930
The fundamental molecular pathogenesis of this disease process remains poorly understood. A significant breakthrough was made with the identification of heterozygous loss-of-function mutations in the bone morphogenetic protein (BMP) type 2 receptor (BMPR2) as the genetic abnormality underlying the rare heritable form of PAH (HPAH) and in a significant proportion (10% to 40%) of patients with IPAH without a family history. 5 These mutations cause attenuation of the normal cellular responses to the BMPs in the lung, where BMP2 and BMP4 play particularly important roles, resulting in pulmonary hypertension. 6 -12 The BMPs bind to transmembrane receptors formed by dimerization of BMPR1 and BMPR2, after which the intracellular kinase domain of BMPR2 phosphorylates its BMPR1 partner, thus initiating downstream signaling, including phosphorylation of Smad1/5/8. 13 Subsequent studies reported that reduced BMP signaling was found in many common forms of pulmonary hypertension that are not caused by BMPR2 mutations, including hypoxic pulmonary hypertension. 9, 14, 15 However, it was not understood what mechanism caused reduced BMP signaling in these conditions. Additionally, it was unclear why only a small proportion (Ϸ15% to 20%) of family members with BMPR2 mutations develop HPAH or why the vascular abnormality is restricted to the pulmonary circulation when the expression of mutant BMPR2 is ubiquitous in all vascular beds. 16 Using a microarray screening approach, we had previously identified gremlin 1 as one of a cluster of genes whose transcription was selectively increased in hypoxic pulmonary endothelial cells in vitro but was unchanged in the endothelial cells of systemic vessels. 17 This gene was of particular interest in that it encodes for a glycoprotein that is a member of a large family of secreted BMP antagonists that modulate BMP actions. 6, 12, 18 Intriguingly, gremlin 1 binds with high affinity to and blocks the actions of BMP2 and BMP4, the BMPs that play central roles in the homeostasis of the normal pulmonary circulation. 6 -8,12 The aim of this study was to examine the hypothesis that pulmonary hypoxia stimulated increased gremlin 1 expression in and secretion from the vascular endothelium, inhibited endogenous BMP signaling, and thus contributed to the development of pulmonary hypertension.
Methods
Detailed methods are available in the online-only Data Supplement.
Mice
Gremlin 1 heterozygote knockout (grem1 ϩ/Ϫ ) mice and wild-type littermates were bred and genotyped as described previously. 19, 20 All procedures were approved by the University College Dublin Animal Research Ethics Committee and carried out under license.
Male adult mice (age, 10 -12 weeks) were exposed to hypoxic conditions in an environmental chamber (FIO 2 ϭ0.10) for periods from 3 hours to 3 weeks, and age-and weight-matched controls were maintained in normoxic conditions (FIO 2 ϭ0.21). 2, 21 Then, mice were killed by exsanguination under anesthesia for isolation of tissues, which were frozen for later extraction of protein for immunoblotting and mRNA for real-time polymerase chain reaction. 17
Immunostaining
Mouse lungs were removed postmortem and fixed, and waxembedded sections were prepared for immunohistochemical and immunofluorescent staining as previously described. 22 Specimens from human lungs with IPAH and HPAH were obtained at the time of transplantation; control specimens were obtained from lung tissue resected during surgery for cancer at a site remote from the tumor. All patients gave informed consent.
Cell Culture
Primary human pulmonary microvascular endothelial cells (Lonza Bioscience) were cultured in hypoxic (1% O 2 , 5% CO 2 , and 94% N 2 ) or control (21% O 2 , 5% CO 2 , and 74% N 2 ) conditions for 48 hours. Scratch closure assays in endothelial monolayers were undertaken as previously described. 17 To knock down endogenous hypoxia-inducible factor (HIF)-1␣ or HIF2␣, cells (human microvascular endothelial cells from the lung) were transfected with HIF1␣-or HIF2␣-specific siRNA, respectively (10 nmol/L; Smartpool, Dharmacon), with lipofectin (Invitrogen Life Technologies). A nontargeting siRNA was used as a negative control. After transfection, cells were placed in normoxic or hypoxic (1% O 2 ) conditions for a further 48 hours and then lysed for RNA extraction. HIF1␣, HIF2␣, and gremlin 1 mRNA expression was measured by real-time polymerase chain reaction.
Assessment of Pulmonary Vascular Resistance
Pulmonary vascular resistance was assessed with an isolated ventilated lung preparation perfused at constant flow. 2, 22 Afterward, the hearts were fixed for later determination of right and left ventricular weights.
Stereological Morphometry
After anesthesia, anticoagulation, and exsanguination, mouse lungs were perfused with horse blood at standard pressure (30 cm H 2 O) and fixed with intratracheal glutaraldehyde (25 cm H 2 O). Left lung volumes were measured, and lungs were then processed to obtain isotropic, uniform, random resin-embedded sections (1 m) for stereological quantification of the pulmonary vasculature ( Figure I in the online-only Data Supplement) by a blinded reviewer. 21
Statistical Analyses
Normally distributed data are reported as meanϮSEM, and nonnormally distributed data are presented as medianϮinterquartile range. For normally distributed data, the statistical significance of differences between 2 group means in planned a priori comparisons was determined with the use of paired or unpaired t tests. For nonnormally distributed data, statistical significance was determined with the Mann-Whitney rank-sum (unpaired) or Wilcoxon signed-rank (paired) tests; P values were computed with the exact (permutation) method. Multiple post hoc comparisons were made with the Holms-Sidak step-down test. 23 Values of PϽ0.05 were accepted as significant.
Results

Expression of Gremlin 1 in Hypoxic Pulmonary Endothelium
In normoxic mice, gremlin 1 was expressed more highly in the lung than in a panel of other organs, including the heart, kidney, and liver ( Figure 1A ). On exposure to hypoxia, gremlin 1 expression increased rapidly within hours and reached a peak value during the first days of exposure, demonstrating that the increase was an early hypoxic response ( Figure 1B ) that had returned to baseline after 2 weeks. This period corresponds to the interval during which hypoxia-induced vascular remodeling is largely completed. 24 Interestingly, basal expression of gremlin 2, a secreted BMP antagonist that is highly homologous to gremlin 1 and binds to BMP2 and BMP4 with high affinity, 6, 12 was also markedly higher in the lung than in other organs, although it was not upregulated by hypoxia (Figures IIA and IIIA in the onlineonly Data Supplement). Noggin and chordin, 2 other secreted BMP antagonists that inhibit BMP2 and BMP4 actions, 6, 12 were not highly expressed in the lung under basal conditions and did not show hypoxia-induced changes (Figures IIB, IIC, IIIB, and IIIC in the online-only Data Supplement).
Immunohistochemical staining showed gremlin in the small intra-acinar vessels of hypoxia-exposed lungs in a distribution suggesting endothelial localization ( Figure 1C and 1D), which was increased compared with normoxic lungs ( Figure 1E and 1F). In contrast, gremlin staining was minimal or absent in the endothelium and media of large muscularized pulmonary vessels under both normoxic ( Figure 1G and 1H) and hypoxic ( Figure 1I and 1J) conditions. Hypoxia also caused increased gremlin staining within the alveolar walls ( Figure IVA 
BMP Signaling in Hypoxic Lungs
BMP2 and BMPR2 protein levels were significantly reduced after 2 days of exposure to hypoxia (Figure 2A ), whereas BMP4 and BMPR1A protein were not significantly altered. Smad1/5/8 phosphorylation was reduced, demonstrating an overall reduction in BMP-mediated cell signaling ( Figure 2B and 2C). Correspondingly, expression of the BMP-regulated gene Id1 was also reduced and remained attenuated after 2 weeks of hypoxia, in agreement with previous reports of persistently reduced BMP signaling in hypoxic lungs. 14, 25 
Hypoxia Stimulates Gremlin Secretion From Human Pulmonary Microvascular Endothelial Cells, Which Blocks Endothelial BMP Signaling
Exposure of cultured human pulmonary microvascular endothelial cells to hypoxia (48 hours) caused increased gremlin 1 expression, which was abolished by siRNA-mediated knockdown of HIF2␣ but not by knockdown of HIF1␣ ( Figure 3 ). Effective HIF1␣ and HIF2␣ knockdown was confirmed by real-time polymerase chain reaction ( Figure V in the onlineonly Data Supplement). Because HIF-dependent gene transactivation in hypoxia results from hypoxia-induced prolyl hydroxylase inhibition, we examined the effect of a lowmolecular-weight inhibitor of prolyl hydroxylases, dimethyloxalylglycine, 26, 27 and found that it also caused increased gremlin expression, an action that was blocked by HIF2␣ knockdown ( Figure VIA in the online-only Data Supplement). In contrast to the endothelial cells, gremlin 1 expression in human pulmonary artery smooth muscle cells was not altered by hypoxia ( Figure VIB in the online-only Data Supplement).
Endothelial secretion of gremlin into the medium was significantly increased after hypoxic exposure ( Figure 4A ). Mean BMP2 concentration in the medium in hypoxia was lower than that in normoxic medium, although this difference was not significant (Pϭ0.07), whereas mean BMP4 secretion was significantly increased by hypoxia ( Figure 4B and 4C). The net effect of these changes was reduced BMP signaling, as demonstrated by reduced Smad1/5/8 phosphorylation and reduced Id1 expression ( Figure 4D and 4E).
Effects of Hypoxia-Induced Gremlin 1 Secretion on BMP Actions in Pulmonary Microvascular Endothelial Cells
Basal Smad1/5/8 phosphorylation was observed in the endothelial cells in normoxia in vitro, which was significantly reduced by the addition of recombinant gremlin 1 to the medium ( Figure 5A and 5C and Figure VII in the online-only Data Supplement). This inhibitory action of gremlin 1 is compatible with an autocrine action of the BMP2 and BMP4 secreted by these cells under basal conditions ( Figure 5A and 5C). Recombinant BMP2 stimulated a marked increase in Smad1/5/8 phosphorylation over basal conditions, an action that was blocked by recombinant gremlin 1 ( Figure 5A and 5C). Cell culture medium conditioned by previous exposure to hypoxic endothelial cells (48 hours) reduced BMP2induced Smad1/5/8 phosphorylation to basal values in a manner similar to recombinant gremlin 1 ( Figure 5A and 5C), a functional activity compatible with the high gremlin concentrations that we had demonstrated in hypoxia medium ( Figure 4A ). Importantly, both recombinant gremlin 1 and hypoxia-conditioned medium also blocked BMP4-induced To further examine the function of gremlin in the hypoxiaconditioned medium, we used a goat anti-gremlin antibody that antagonized the activity of recombinant gremlin 1 (Figure IX in the online-only Data Supplement). Addition of this blocking antibody to hypoxia-conditioned medium from endothelial cells abolished the inhibitory action of the medium on BMP2-induced Smad1/5/8 phosphorylation ( Figure 5B and 5C), demonstrating that gremlin was the predominant antagonist of BMP2/BMP4 signaling in the hypoxic medium.
To investigate the functional effects of gremlin 1 on the pulmonary microvascular endothelial cells, we used a scratch closure assay that examines the repair and regeneration of an endothelial cell monolayer. MeanϮSEM closure in vehicletreated monolayers was (31.2Ϯ3.4%), which was not significantly changed after treatment with gremlin 1 (Figure 5D and 5F). BMP2 treatment enhanced the rate of scratch closure, an action that was blocked by treatment with recombinant gremlin 1 ( Figure 5D and 5F). Hypoxia-conditioned medium blocked the BMP2-induced scratch closure in a manner similar to recombinant gremlin 1 ( Figure 5E and 5F). Addition of the anti-gremlin antibody to hypoxia-conditioned medium from endothelial cells abolished the inhibitory action of the medium on BMP2-induced scratch closure ( Figure 5E and 5F). These data show that hypoxia stimulates gremlin secretion from human pulmonary microvascular endothelial cells and that this secreted gremlin can block both BMP signaling in the endothelium and BMP-induced regeneration and repair.
Haplodeficiency of Gremlin 1 Attenuates Hypoxia-Induced Increases in Pulmonary Vascular Resistance
To test the hypothesis that gremlin 1 contributes significantly to the development of pulmonary hypertension in vivo, we examined changes in pulmonary vascular resistance in response to sustained hypoxia in mice with haplodeficiency of gremlin 1 caused by monozygous null mutations (grem1 ϩ/Ϫ ); homozygous loss of gremlin 1 (grem1 Ϫ/Ϫ ) causes embryonic or perinatal lethality. 20 Haplodeficient mice showed reduced expression of gremlin 1 and enhanced BMP signaling in both normoxia and hypoxia ( Figure XA and XB in the online-only Data Supplement). The effect of haplodeficiency of gremlin 1 on the development of pulmonary hypertension was tested by exposing wild-type and grem1 ϩ/Ϫ mice to hypoxia (FIO 2 ϭ 0.10) for 3 weeks. Pulmonary vascular resistance in the grem1 ϩ/Ϫ mice was significantly less than that in the wildtype group ( Figure 6A ) after hypoxic exposure. Hypoxic pulmonary vascular resistance in wild-type mice increased by 85Ϯ3.2% of the mean normoxic value, whereas that in the haplodeficient group increased by significantly (PϽ0.01) less (63Ϯ4.3%). Thus, gremlin 1 haplodeficiency attenuated the hypoxia-induced increase in pulmonary vascular resistance. The ratio of right ventricular to left ventricular plus septal weight was significantly increased in both hypoxic grem1 ϩ/Ϫ and wild-type mice compared with the matched normoxic groups ( Figure 6B) .
In contrast to the reduced pulmonary vascular resistance observed in hypoxia, grem1 ϩ/Ϫ mice showed an elevation of hematocrit similar to that in wild-type mice ( Figure 6C ), demonstrating that the extrapulmonary, HIF-mediated erythropoietic response was unaffected by gremlin 1 haplodeficiency. 28
Haplodeficiency of Gremlin 1 Attenuates Hypoxic Pulmonary Vascular Remodeling
The increased pulmonary vascular resistance caused by chronic hypoxia has 2 components: vasoconstriction and structural reduction in lumen diameter caused by vascular remodeling. To assess the vasoconstrictor element, we used the potent rho kinase inhibitor and vasodilator Y27632. 2 We observed small reductions in resistance in normoxic lungs ( Figure 6D ) as expected. In chronically hypoxic lungs, rho kinase inhibition caused significant reductions in resistance (Ϸ40% of the chronic hypoxia-induced increase) that were similar in wild-type and grem1 ϩ/Ϫ mice ( Figure 6D ). However, in both wild-type and grem1 ϩ/Ϫ mouse lungs, pulmonary vascular resistance remained significantly above the normoxic value after rho kinase inhibition ( Table II in the online-only Data Supplement). These data demonstrated that haplodeficiency of gremlin 1 did not alter chronic hypoxiainduced vasoconstriction.
After sustained hypoxic exposure, the walls of small intra-acinar vessels of wild-type mice showed characteristic thickening in response to 3 weeks of hypoxia, which was reduced in the hypoxic grem1 ϩ/Ϫ mice ( Figure 7A ). Wildtype mice showed a typical increase in lung volume in response to sustained hypoxia, which was not observed in grem1 ϩ/Ϫ mice ( Figure XI in the online-only Data Supplement). Stereological analysis showed that wall thickness in the smaller intra-acinar vessels of hypoxic lungs was significantly less in grem1 ϩ/Ϫ mice than in wild-type mice ( Figure  7B ). In wild-type mice, sustained hypoxia caused a significant reduction in mean lumen diameter of these vessels, which was not observed in grem1 ϩ/Ϫ mice ( Figure 7C ). The mean total length of intra-acinar vessels was unchanged by chronic hypoxia in both wild-type and grem1 ϩ/Ϫ mice (Figure 7D) , although interestingly length density was reduced in hypoxic lungs ( Table I in the online-only Data Supplement). The volume and length of vessels in the smallest-diameter category were significantly increased in the grem1 ϩ/Ϫ mice after hypoxic exposure, although to a lesser extent than in wild-type mice ( Figure 7E and 7F) . These data show that in wild-type mice there was a reduction in the lumen diameter of the intra-acinar vessels, leading to an increase in the length of vessels included in the smallest category (10 -20 m). Because of the inverse fourth-power relationship between radius and vascular resistance (the Poiseuille equation), the reduction in mean lumen diameter (Ϸ10%) in wild-type mice ( Figure 7C ) could completely account for the structural component of the increased vascular resistance (Table II in ; nϭ6) . B, BMP2 concentration (meanϮSE) in cell culture medium was not significantly altered (Pϭ0.07) with hypoxia (nϭ6), whereas (C) BMP4 concentration (meanϮSE) was enhanced (nϭ6). D, Western blot showing that Smad1/5/8 phosphorylation (meanϮSE) was reduced in hypoxia (nϭ6). E, Id1 mRNA expression (meanϮSE) was downregulated after hypoxic exposure (nϭ6). Cells were exposed to hypoxia for 48 hours in all experiments (nϭ6). *PϽ0.05 and **PϽ0.01, significantly different from matched normoxic group.
the online-only Data Supplement). In contrast, in the haplodeficient mouse lungs, these structural changes were significantly attenuated, markedly reducing the structurally mediated increases in resistance ( Table II in 
Gremlin Expression in Vessels of Explanted Human PAH Lungs
Immunohistochemical staining of sections taken from lungs explanted from patients with IPAH and HPAH showed staining for gremlin that suggested endothelial localization Figure 5 . Hypoxia-induced gremlin 1 secretion blocks bone morphometric protein (BMP) signaling and scratch closure in pulmonary microvascular endothelial cells. A, Exogenous BMP2 (100 ng/mL) induced Smad1/5/8 phosphorylation, which was blocked by exogenous gremlin 1 (2 g/mL). B, Hypoxia-conditioned medium blocked BMP2 (100 ng/mL)-induced Smad1/5/8 phosphorylation, which was restored by preincubating hypoxic conditioned medium (CM) with anti-gremlin antibody (15 g/mL). C, Densitometric (medianϮinterquartile range) analysis of phospho (p)-Smad blots. Vehicle (nϭ9), gremlin (nϭ6), BMP (nϭ9), gremlinϩBMP2 (nϭ6), hypoxic CMϩBMP2 (nϭ6), BMP2ϩCMϩanti-gremlin antibodies (nϭ6). D, BMP2 (100 ng/mL) induced scratch closure (measured at 24 hours), which was blocked by recombinant gremlin 1 (2 g/mL) and restored by preincubating hypoxic CM with anti-gremlin antibody (15 g/mL). E, BMP2 (100 ng/mL) treatment-induced scratch closure was blocked by hypoxic CM in a manner similar to blockade by recombinant gremlin 1 and restored by anti-gremlin antibody (15 g/mL). F, Scratch healing (meanϮSEM) in all groups. Vehicle (Veh; nϭ9), gremlin (Grem; nϭ6), BMP2 (nϭ9), gremlinϩBMP2 (nϭ6), hypoxic CMϩBMP2 (nϭ6), BMP2ϩCMϩanti-gremlin antibody (nϭ6). *PϽ0.05 and **PϽ0.01, significantly different from vehicle-treated cells. #PϽ0.05 and ##PϽ0.01, significantly different from BMP2treated cells. $$PϽ0.01, significantly different from hypoxic CMϩBMP2-treated cells.
( Figure 8A-8D ), which was more marked than that observed in control lungs ( Figure 8E-H) . Gremlin was not seen in the cells of the immediately adjacent vascular wall, either in the remodeled vessels in PAH or in normal lungs, suggesting that the endothelium was the predominant source of gremlin in the small resistance vessel walls. In plexiform lesions, immunostaining was variable, with some vascular channels demonstrating intense staining and others showing much less or absent staining ( Figure 8I-8N ).
Discussion
We report here that the BMP antagonist gremlin was increased in the walls of the small vessels of the pulmonary circulation in vivo during the development of hypoxic pulmonary hypertension. Hypoxia increased gremlin secretion from endothelial cells in vitro, which blocked BMP signaling in and regeneration of endothelial cell monolayers. Haplodeficiency of gremlin 1 prevented the reduction of BMP signaling observed in wild-type hypoxic mouse lung in vivo, inhibited pulmonary vascular remodeling, and thus attenuated the development of increased pulmonary vascular resistance without altering hypoxic vasoconstriction. Furthermore, gremlin was increased in the small pulmonary vessels of the explanted lungs from patients with HPAH and IPAH.
Gremlin 1 was originally identified as a gene that encodes a small glycoprotein (23-28 kDa) that binds noncovalently to specific ligands of the BMP family (BMP2, BMP4, and BMP7), thus preventing interaction with BMPR1 and BMPR2. 6 After glycosylation and secretion, gremlin 1 binds noncovalently to the cell surface and extracellular matrix, thus tending to act locally to reduce the effective free concentration of BMPs and to inhibit signaling in cells closely adjacent to its sites of production. 29 Gremlin 1 is highly expressed in the mouse lung during embryonic development 6 ; moreover, homozygous deletion of gremlin 1 prevents normal lung development as a result of reduced septation. 20 Overexpression of gremlin 1 in the lung during development also impairs normal lung formation by disrupting normal airway branching and formation. 6 Thus, the balanced actions of BMPs and gremlin 1, coordinated both spatially and temporally, are required for normal lung development.
Attenuation of BMP signaling specifically in the endothelium by selective deletion of BMPR2 is sufficient to cause pulmonary vascular remodeling and the spontaneous development of pulmonary hypertension in mice. 11 In keeping with this, the endothelium is the predominant site of BMPR2 expression in the normal pulmonary vessels, and normal BMP signaling is required for survival of pulmonary endothelial cells. 11, 14, 30, 31 Conversely, overexpression of BMPR2 in the endothelium protected mice against the development of hypoxic pulmonary hypertension. 32 BMPR signaling in pulmonary vascular smooth muscle cells is also required to maintain low vascular smooth muscle tone, to prevent abnormal proliferation, and to maintain normal medial structure. 10, 33 Recent evidence demonstrates that BMP2 produced by the endothelium is the major BMP ligand activating the BMPRs in the pulmonary vascular wall. 7 These data show that endothelial BMP signaling is essential for homeostatic maintenance of normal pulmonary vascular structure and function. Thus, the increased gremlin expression and secretion from the hypoxic pulmonary endothelium that we have demonstrated are optimally placed to inhibit the actions of BMP2 secreted by the pulmonary endothelium, which are required to maintain normal pulmonary vascular resistance. 7 Increased gremlin may not be the only reason for reduced BMP mediated signaling; we also demonstrated reduced BMP2 and BMPR2 expression in the hypoxic lung ( Figure 2) . Nonetheless, our finding that mono-allelic loss of gremlin was sufficient to attenuate the hypoxia-induced increase in pulmonary vascular resistance emphasizes the importance of this molecule in the pathogenesis of the disease. These results underestimate the effects of gremlin because, in the haplodeficient mouse, gremlin expression, although reduced, was still present and increased in response to hypoxia, although to lower levels and with less effect on BMP signaling than in hypoxic wild-type mice. Taken together, these data provide evidence for a novel autocrine-paracrine axis consisting of the balanced actions of BMP2, BMP4, and gremlin 1 operating homeostatically in the pulmonary vascular endothelium and adjacent vessel wall to maintain the normal pulmonary vascular structure and function.
Our data suggest that alveolar hypoxia such as that found in lung diseases stimulates the pulmonary microvascular endothelium to secrete gremlin 1. Given that haplodeficiency of HIF2␣ in mice prevents the development of hypoxic pulmonary hypertension, 34 it is interesting that the hypoxiainduced increases in gremlin 1 expression in pulmonary microvascular endothelial cells required HIF2␣. Moreover, pulmonary hypertension in the HIF2␣-deficient mouse was prevented by reduced pulmonary vascular remodeling without any effect on acute hypoxic vasoconstriction, a pattern of change similar to that which we observed in grem1 ϩ/Ϫ mice. 34 Although we provide evidence that HIF2␣ is required for hypoxic induction of gremlin 1 expression in the pulmo-nary microvascular endothelium, it remains to be determined how it acts in this context. HIF controls gene expression directly by binding to hypoxia response elements in the proximal promoter but also at sites remote from the regulated gene. 26, 35 HIF also regulates genes indirectly by interactions with other transcription factors, by stabilization of mRNAs, and by regulation of microRNAs. [35] [36] [37] [38] [39] [40] Taken together, these data provide an explanation for the reduction in BMP signaling previously reported in chronically hypoxic hypertensive lungs in the absence of BMPR2 mutations. 15 Furthermore, because the hypoxic increase in gremlin 1 is restricted to the lung and is not observed in other organs, these data identify a mechanism that can account for the structural component of the increase in vascular resistance in response to sustained hypoxia, which is unique to the pulmonary circulation, such as that observed in chronic lung diseases and at high altitude. 17 Pulmonary vascular remodeling occurs rapidly after the onset of alveolar hypoxia (within the first day) and is largely completed within a few weeks. In their classic studies, Meyrick and Reid 41 showed that cellular proliferation in the within each vessel size category (based on lumen diameter) was significantly less in the smaller vessels in grem1 ϩ/Ϫ mice compared with wild-type mice after 3 weeks of hypoxic exposure (nϭ8 per group). C, The mean lumen diameter (meanϮSE) was significantly decreased in wild-type mice after 3 weeks of hypoxic exposure but was not significantly altered in grem1 ϩ/Ϫ mice. D, The total length of intra-acinar vessels (medianϮinterquartile range) was similar in both normoxic and hypoxic wild-type and grem1 ϩ/Ϫ groups. E, The volume of the vessel lumen (medianϮinterquartile range) within each size category of vessel in normoxic and hypoxic condition in wildtype and grem1 ϩ/Ϫ mouse lungs and (F) the length of vessel (medianϮinterquartile range) within each vessel category. Within the smallest category, volume and length were increased after sustained hypoxia, although these changes were significantly less in the grem1 ϩ/Ϫ group. #PϽ0.05, significantly different from hypoxic wild-type group. *PϽ0.05, significantly different from matched normoxic group of same genotype. pulmonary vasculature of hypoxic rats peaked during the first week and then declined to baseline after 14 days; medial and adventitial hypertrophy reached a plateau after 10 days and then remained stable during continued exposure. Thus, blocking active remodeling during this early period could have sustained effects on pulmonary vascular structure. It is interesting that this corresponds to the period during which gremlin rises to its peak expression and returns to baseline in hypoxic wild-type mice (Figure 1 ). Our results in haploinsufficient mice show that a reduction in gremlin 1 during that early period attenuates the hypoxia-induced increase in pulmonary vascular resistance. However, we also found changes in other elements of the BMP signaling pathway, including both BMP ligands and BMPR (Figures 2 and 4 ). Furthermore, gremlin can act by mechanisms that are independent of its extracellular blockade of BMP ligands, including the vascular endothelial growth factor pathway, Slit-Robo interactions, and intracellular mechanisms. 6, 42 Thus, the longer-term effects (Ͼ3 weeks of hypoxia) of gremlin haploinsufficiency on both signaling and vascular resistance in pulmonary hypertension remain to be elucidated.
In idiopathic pulmonary fibrosis, which causes alveolar hypoxia and vascular loss, pulmonary hypertension is a prominent feature and is associated with a poor prognosis. 43 Recently, it has been reported that gremlin 1 expression is significantly increased in idiopathic pulmonary fibrosis lungs, which, in the light of our results, suggests that gremlin 1 may play an important role in causing pulmonary hypertension in this disease. 44 Because the hypoxia-induced increase in gremlin 1 is selective for the lung, it offers an attractive potential target for therapy because antagonism of its actions might have minimal effects in other organs.
Our finding of increased gremlin expression in the walls of pulmonary vessels in explanted lungs from patients with IPAH and HPAH in a pattern compatible with endothelial expression suggests that gremlin may play a pathogenic role in these and other forms of PAH not caused by alveolar hypoxia. Furthermore, the high basal levels of both gremlin 1 and gremlin 2 in the lung may render it particularly susceptible to any further reductions in BMP signaling resulting from heterozygous mutations in BMPR2, whereas in other organs the remaining BMPR2 signaling, although haplodeficient, could be sufficient to maintain vascular homeostasis. 5
Conclusions
We report a lung-selective, early-onset, hypoxia-induced increase in gremlin 1 expression that plays an important pathogenic role in the development of pulmonary hypertension by promoting vascular remodeling and thus increasing pulmonary vascular resistance while leaving hypoxic vasoconstriction unchanged. This finding identifies, for the first time, a molecular mechanism that accounts for the unique vascular remodeling of the pulmonary circulation in response to hypoxia. Furthermore, the high levels of expression of gremlin 1 and gremlin 2 in the lung may render it particularly vulnerable to further reductions in BMP signaling resulting from heterozygous loss-of-function mutations of BMPR2 in HPAH and thus may account for the development of vascular remodeling, increased vascular resistance, and hypertension in the pulmonary circulation while other vascular beds remain unharmed. (IPAH; A and B) , 2 rare heritable form of PAH (HPAH; C and D), and 4 control (E-H) lungs showing gremlin immunohistochemical staining (brown; arrowheads). Low-intensity staining was observed in vessels in control lungs; there was marked staining in the small remodeled vessels in the hypertensive lungs in a pattern compatible with endothelial localization (ϫ100 objective; scale barϭ20 m). In plexiform lesions (I and L), endothelial immunostaining was variable (ϫ40 objective; scale barϭ100 m), with some vascular channels demonstrating intense staining (J, K, and N) and others showing no staining (M; ϫ100 objective; scale barϭ50 m).
